This is custom heading element
Which problem does your company aim to solve?
Crevoisier (img: Dave Joly)
Yann Duscher, Crevoisier: Crevoisier wants to provide equipment that increases the productivity and quality rates of its customers.
When and why did you found your company?
Crevoisier was founded in 1966 in order to provide quality mechanical parts.
What does winning the i4Challenge mean to you?
It’s a great reward, especially for the company, the team and all the people who have worked hard to make this ambitious project succeed. It also translates into personal satisfaction because it proves the quality of our work and that we had the correct vision by innovating in the area of 4.0 and including collaborative robots in our next step.
What does the term “Industry 4.0” mean to you and why is the topic relevant?
Industry 4.0 corresponds to equipment connectivity and data evaluation. The topic is important because it is the continuation, the evolution of the industry: Interconnection, production monitoring, machines that are linked to each other, and competent people who can monitor their production, who can intervene early enough if there is an issue and are able to change the manner of intervention to make it happen. Production monitoring is extremely important today. You can control it from home by using a computer, you can talk and interact with the machines, you can involve people from all over the world, so Industry 4.0 is the future, it’s the industry of today.
Where do you see the development in the region?
Generally speaking, concrete solutions exist in the region, from software and connected machines to cobotics. However, there is a lack of qualified personnel to develop and integrate its solutions and this is really slowing down our economy.
What are your plans for your company?
We want to build a new factory to consolidate our four sites under the same roof. In addition, we are currently producing a new type of machines which will soon be available.
Share this article
You might also be interested in
A research project is investigating the improvement in the condition of patients who have been hospitalized due to COVID-19. docdok.health based in Basel is contributing the smartphone app for the project.Read More
The Allschwil-based pharmaceutical company Idorsia receives a payment of 45 million US dollars as part of an agreement with Neurocrine Biosciences and shall also be entitled to claim milestone payments in future. Neurocrine has exercised a licensing option for a drug developed by Idorsia to treat epilepsy..Read More
Roche has received Emergency Use Authorization in the USA for an antibody test in connection with the novel coronavirus. The tests are already being distributed around the world. In May, production capacities are to already be scaled up to the high double-digit million area.Read More
Basel is valued as a location for company headquarters. In a rating from the fDi Intelligence platform of the Financial Times, Basel achieves eighth place in Europe. No other Swiss city does better.Read More
The investment and innovation promotion agency Basel Area Business & Innovation, previously known as BaselArea.swiss, can look back on a successful year in 2019. In this regard, positive developments in the healthtech sector and in Switzerland Innovation Park Basel Area stand out.Read More
The University Hospital Basel is the first Swiss hospital to have treated two Covid-19 patients with the plasma from a patient who has recovered from the virus, which means that they are receiving the appropriate antibodies. This method is a potential therapeutic option.Read More